IVIX Ltd. Report issue

For profit Phase 3
Founded: Moscow Russian Federation (2012)

Organization Overview

First Clinical Trial
2016
NCT03080298
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Ivix LLC | Ivix LLX

Active Ingredients

Drugs in Phase 3 Trials (1)

bp101 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Disease (Phase 3)

Sexual Dysfunctions, Psychological (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 1